RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
79 hedge funds and large institutions have $644M invested in Revance Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 36 increasing their positions, 19 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
10% less funds holding
Funds holding: 88 → 79 (-9)
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
Holders
79
Holding in Top 10
2
Calls
$6.6M
Puts
$1.01M
Top Buyers
| 1 | +$18.2M | |
| 2 | +$5.28M | |
| 3 | +$5.23M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.63M |
| 5 |
Goldman Sachs
New York
|
+$2.13M |
Top Sellers
| 1 | -$2.55M | |
| 2 | -$1.66M | |
| 3 | -$1.61M | |
| 4 |
Renaissance Technologies
New York
|
-$1.22M |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
-$1.09M |